Long term interferon and ribavirin combination therapy in chronic hepatitis C patients unresponsive to interferon monotherapy.

被引:0
|
作者
Anderson, FH [1 ]
Rock, NR [1 ]
Sherlock, C [1 ]
机构
[1] Univ British Columbia, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2213
引用
收藏
页码:716A / 716A
页数:1
相关论文
共 50 条
  • [1] Interferon alfa 2B and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon monotherapy.
    Hajjar, B
    Galica, M
    Weisz, K
    Salen, G
    Dieterich, DT
    [J]. HEPATOLOGY, 1999, 30 (04) : 624A - 624A
  • [2] Interferon plus ribavirin in hemophiliacs with chronic hepatitis C nonresponder to interferon monotherapy.
    Tagliaferri, A
    Rossetti, G
    Franchini, M
    Pattacini, C
    Bertuzzo, D
    Capra, F
    De Maria, E
    Gandini, G
    [J]. BLOOD, 2002, 100 (11) : 710A - 710A
  • [3] The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
    Hiramatsu, N
    Kasahara, A
    Nakanishi, F
    Toyama, T
    Tsujii, M
    Tsuji, S
    Kanto, T
    Takehara, T
    Kato, M
    Yoshihara, H
    Naito, M
    Katayama, K
    Hijioka, T
    Hagiwara, H
    Kubota, S
    Oshita, M
    Meren, H
    Masuzawa, M
    Haruna, Y
    Mita, E
    Suzuki, K
    Hayashi, N
    [J]. HEPATOLOGY RESEARCH, 2004, 29 (03) : 142 - 147
  • [4] Combination therapy for chronic hepatitis C: interferon and ribavirin
    Christie, JML
    Chapman, RWG
    [J]. HOSPITAL MEDICINE, 1999, 60 (05): : 357 - 361
  • [5] Treatment of chronic hepatitis C in nonresponders to interferon monotherapy.
    Kwo P.Y.
    [J]. Current Gastroenterology Reports, 2000, 2 (1) : 11 - 17
  • [6] Immunological and mutagenic actions of ribavirin monotherapy preceding combination therapy with interferon for patients with chronic hepatitis C
    Ogawa, Koji
    Hige, Shuhei
    Nakanishi, Mitsuru
    Yamamoto, Yoshiya
    Chuma, Makoto
    Nagasaka, Atsushi
    Asaka, Masahiro
    [J]. ANTIVIRAL THERAPY, 2009, 14 (04) : 513 - 522
  • [7] Immunological action of ribavirin monotherapy preceding to combination therapy with interferon for patients with chronic hepatitis C.
    Ogawa, K
    Hige, S
    Chuma, M
    Nagasaka, A
    Asaka, M
    [J]. HEPATOLOGY, 2004, 40 (04) : 393A - 393A
  • [8] Treatment of chronic hepatitis C in patients who failed interferon monotherapy: Effects of higher doses of interferon and ribavirin combination therapy
    Shiffman, ML
    Hofmann, CM
    Gabbay, J
    Luketic, VA
    Sterling, RK
    Sanyal, AJ
    Contos, MJ
    Ryan, MJ
    Yoshida, C
    Rustgi, V
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10): : 2928 - 2935
  • [9] Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-α combination therapy and interferon-α monotherapy of patients with chronic hepatitis C
    Hoffmann, RM
    Berg, T
    Teuber, G
    Prümmer, O
    Leifeld, L
    Jung, MC
    Spengler, U
    Zeuzem, S
    Hopf, U
    Pape, GR
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1999, 37 (08): : 715 - 723
  • [10] Continued ribavirin monotherapy following interferon-ribavirin combination therapy is not effective for chronic hepatitis C
    Kakumu, S
    [J]. HEPATOLOGY RESEARCH, 2005, 32 (02) : 77 - 78